| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 21,861 | 23,397 | 23,302 | 20,417 | | Cost of Revenue | 3,528 | 3,993 | 3,996 | 3,984 | | | Gross Profit |
-
| 19,404 | 19,306 | 16,433 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,929 | 9,928 | 9,397 | 8,230 | | Non Recurring | (166) | 32 | 134 |
-
| | Others | 3,416 | 3,290 | 3,197 | 2,163 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 6,154 | 6,578 | 6,040 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 6,154 | 6,154 | 6,578 | 6,040 | | Interest Expense | 3,238 | 3,593 | 3,262 | 3,375 | | Income Before Tax | 2,916 | 2,561 | 3,316 | 2,665 | | Income Tax Expense | 559 | 497 | 681 | 543 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,357 | 2,064 | 2,635 | 2,122 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,357 | 2,064 | 2,635 | 2,122 | | Preferred Stock And Other Adjustments | (351) | (350) | (350) |
-
| | | Net Income Applicable To Common Shares | $2,006 | $1,714 | $2,285 | $2,122 |
|
0.51% Nasdaq 
Income Statement
